10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 341 filers reported holding 10X GENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,155 | -62.0% | 28 | -50.0% | 0.00% | – |
| Q2 2023 | $3,041 | +105.9% | 56 | +100.0% | 0.00% | – |
| Q1 2023 | $1,477 | +36825.0% | 28 | -62.2% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 74 | -56.7% | 0.00% | – |
| Q3 2022 | $14,000 | 0.0% | 171 | +1.2% | 0.00% | – |
| Q2 2022 | $14,000 | -22.2% | 169 | -23.9% | 0.00% | – |
| Q1 2022 | $18,000 | +260.0% | 222 | +534.3% | 0.00% | – |
| Q4 2021 | $5,000 | +25.0% | 35 | +25.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 28 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | – | 28 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 10 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2019 | $47,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |